Abstract
The NCCN Guidelines for Colorectal Cancer (CRC) Screening outline various screening modalities as well as recommended screening strategies for individuals at average or increased-risk of developing sporadic CRC. The NCCN panel meets at least annually to review comments from reviewers within their institutions, examine relevant data, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize 2018 updates to the NCCN Guidelines, with a primary focus on modalities used to screen individuals at average-risk for CRC.
Copyright © 2018 by the National Comprehensive Cancer Network.
Publication types
-
Practice Guideline
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Age Factors
-
Aged
-
Aged, 80 and over
-
Biomarkers, Tumor / blood
-
Biomarkers, Tumor / genetics
-
Biomarkers, Tumor / isolation & purification
-
Colonoscopy / methods
-
Colonoscopy / standards
-
Colorectal Neoplasms / blood
-
Colorectal Neoplasms / diagnosis*
-
Colorectal Neoplasms / genetics
-
Colorectal Neoplasms / pathology
-
DNA, Neoplasm / genetics
-
DNA, Neoplasm / isolation & purification
-
Early Detection of Cancer / methods
-
Early Detection of Cancer / statistics & numerical data*
-
Feces / chemistry
-
Humans
-
Immunochemistry / methods
-
Immunochemistry / standards
-
Mass Screening / methods
-
Mass Screening / standards*
-
Medical Oncology / methods
-
Medical Oncology / standards*
-
Middle Aged
-
Occult Blood
-
Randomized Controlled Trials as Topic
-
Septins / genetics
-
Societies, Medical / standards
-
Time Factors
-
Tomography, X-Ray Computed / methods
-
Tomography, X-Ray Computed / standards
-
United States
Substances
-
Biomarkers, Tumor
-
DNA, Neoplasm
-
SEPTIN9 protein, human
-
Septins